verified SJR 0,601 · Q3 • database Scopus / SJR & Web of Science indexed

United States · Academic Press Inc.

workspace_premium Q3 — Oncology lock Subscription

Advances in Cancer Research

Advances in Cancer Research is a book series indexed in SJR in Oncology and Cancer Research with an H index of 113. It has an SJR impact factor of 0,601 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,601.

ISSN: 0065-230X

Publisher: Academic Press Inc.

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,601 Q3

H-index 113

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,601

H-index

113

Docs (year)

Docs 3y

121

Total refs

5405

Cites 3y

858

Citable 3y

Cites/Doc 2y

3.74

Ref/Doc

154.43

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer

Role of CD4 T lymphocytes in antitumor immunity

Regulation of CLU Gene Expression by Oncogenes and Epigenetic Factors

Studies On The Development, Biochemistry, And Biology Of Experimental Hepatomas

Susceptibility of Human Population Groups to Colon Cancer

Telomerase inhibitors: a new option for chemotherapy

The Choice of Animal Tumors for Experimental Studies of Cancer Therapy

The Enzymic Pattern of Neoplastic Tissue

Translation of cancer immunotherapy from the bench to the bedside

Stem Cell-Based Therapies for Cancer

Preface

SHOW MORE ARTICLES

Quantitative Theories of Oncogenesis

Noninvasive Imaging of Reporter Gene Expression in Living Subjects

Molecular Geometry and Carcinogenic Activity of Aromatic Compounds. New Perspectives

microRNAs in Cancer

Mass Spectrometry Imaging in Oncology Drug Discovery

Innate Immune Recognition and Suppression of Tumors

Increasing Complexity of Ras Signal Transduction: Involvement of Rho Family Proteins

Immunotherapy in breast cancer: Current status and future directions

Heterogeneous pathogenicity of retroviruses: lessons from birds, primates, and rodents

GRP94/gp96 in Cancer

Gestational Trophoblastic Disease: Origin of Choriocarcinoma, Invasive Mole and Choriocarcinoma Associated With Hydatidiform Mole, and Some Immunologic Aspects

Functional Impact of Tumor-Specific N-Linked Glycan Changes in Breast and Ovarian Cancers

FAQs

Advances in Cancer Research has an SJR of 0,601 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Advances in Cancer Research is 25%.

Advances in Cancer Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Advances in Cancer Research?

What is the APC / publication cost?

What is the acceptance rate?